Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cytogen/Cellcor $20 mil. merger and $12 mil. subscription offering enhance Cytogen's cash position.

Executive Summary

CYTOGEN/CELLCOR $20 MIL. MERGER AND $12 MIL. SUBSCRIPTION OFFERING will enhance Cytogen's cash position while bringing in Cellcor's proprietary technology with at least one product in late-stage development. The companies jointly announced the signing of a definitive merger agreement June 16. Cytogen was advised in the merger by Smith Barney, and Cellcor was aided by First Boston.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026397

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel